Laidlaw Wealth Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Laidlaw Wealth Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,168	Closed	-$253K	–	281
2021 Q1	$253K	Buy	+1,168	New	+$220K	0.09%	181
2020 Q4	–	Sell	-2,368	Closed	-$231K	–	360
2020 Q3	$231K	Sell	2,368 -1,365	-37%	-$157K	0.1%	182
2020 Q2	$458K	Buy	+3,733	New	+$424K	0.24%	104

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Laidlaw Wealth Management's GWPH Position: Q2 2021 in Review

Laidlaw Wealth Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 1,168 shares — an estimated $253K sold.

Laidlaw Wealth Management first reported a position in GWPH in Q2 2020 and held it in 3 quarters. The position peaked at $458K in Q2 2020. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Laidlaw Wealth Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Laidlaw Wealth Management sold 1,168 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $253K.
Laidlaw Wealth Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2020 and held it in 3 quarters.
Laidlaw Wealth Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $458K in Q2 2020.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Laidlaw Wealth Management's 13F filing for Q2 2021, filed 13 Aug 2021.